tiprankstipranks
GlycoMimetics Announces Merger with Crescent Biopharma
Company Announcements

GlycoMimetics Announces Merger with Crescent Biopharma

GlycoMimetics ( (GLYC) ) has issued an update.

Don't Miss our Black Friday Offers:

GlycoMimetics, Inc. has announced a merger with Crescent Biopharma, aiming to enhance their presence in the biopharma sector. This merger, structured as a tax-free reorganization, will result in Crescent’s shareholders owning a significant majority of the combined entity. The transaction includes a substantial private placement of $200 million to support future growth and development. Both companies’ boards have approved the merger, expected to close in mid-2025, pending various conditions and shareholder approvals.

For an in-depth examination of GLYC stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyLargest borrow rate increases among liquid names
TheFlyLargest borrow rate increases among liquid names
TheFlyLargest borrow rate increases among liquid names
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App